Latest Highlands State Bknj (HSBK) Headlines Savings &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Highlands State Bknj (HSBK) Headlines

Savings & Loans Stocks Technical Notes: Ocwen Financial, New York Community Bancorp, Hudson City Bancorp, and People's United Financial
PR Newswire - Fri Mar 07, 7:00AM CST
On Thursday, March 06, 2014, the NASDAQ Composite ended at 4,352.13, down 0.13%, the Dow Jones Industrial Average advanced 0.38% to 16,421.89, and the S&P 500 closed at 1,877.03, up 0.17%. The gains were broad based with seven of ten sectors edging higher. The S&P 500 Financials Sector Index finished the day at 299.38, up 0.68%, while the same has gained 5.75% in the last one month. Investor-Edge.com has initiated coverage on the following equities Ocwen Financial Corporation (NYSE: OCN), New York Community Bancorp Inc. (NYSE: NYCB), Hudson City Bancorp Inc. (NASDAQ: HSBK), and People's United Financial Inc. (NASDAQ: PBCT). Free research on these five companies can be accessed at:

Highlands State Bank Completes Purchase of Secure Lending Solutions, Inc.
Business Wire - Mon Mar 03, 1:44PM CST
Highlands Bancorp, Inc. (OTCBB: HSBK.OB) is pleased to announce that its wholly owned subsidiary, Highlands State Bank, has completed the purchase of Secure Lending Solutions, Inc., (SLS) after receiving the appropriate regulatory approvals. SLS, a New Jersey licensed mortgage banking company, will be operated as a wholly owned subsidiary of the bank, and continue to operate out of its office at 266 Harristown Road, Glen Rock, NJ. Michele Luff, the company's co-founder and President will continue in that role as the company joins Highlands.

Highlands Bancorp, Inc. Declares its First Quarterly Dividend
Business Wire - Mon Jan 27, 1:33PM CST
The Board of Directors of Highlands Bancorp, Inc. (OTCQB:HSBK) parent company of Highlands State Bank, announced that it has declared a cash dividend of $0.01 per common share. The dividend is payable on March 1, 2014 to common shareholders of record on February 15, 2014.

Highlands Bancorp, Inc. Reports Results for the Quarter and Year Ended December 31, 2013
Business Wire - Fri Jan 24, 10:24AM CST
Highlands Bancorp, Inc. (OTC BB: HSBK.OB) parent company of Highlands State Bank, reported fourth quarter net income of $563,000 in 2013 compared to net income of $1,012,000 for the same period of 2012. Fourth quarter net income available to common stockholders was $545,000 or $.30 per diluted share in 2013 compared to $995,000 or $.56 per diluted share for the same period in 2012. Net income for the full year 2013 was $2,270,000 compared to $1,548,000 for the full year 2012. Net income available to common stockholders for the full year 2013 was $2,201,000 or $1.23 per diluted share compared to $1,484,000 or $.83 per diluted share for the year of 2012. The quarterly and annual results for both 2013 and 2012 were positively impacted by partial reversals of the Company's valuation allowance on deferred tax assets which resulted in tax benefits of $333,000 or $.19 per share for the fourth quarter of 2013 and $640,000 or $.36 per share for the fourth quarter of 2012, and $1,310,000 or $.73 per share and $640,000 or $.36 per share for the years of 2013 and 2012, respectively.

Highlands State Bank signs definitive agreement to acquire mortgage banking company
M2 - Mon Oct 28, 10:42AM CDT
Highlands Bancorp Inc (OTCBB:HSBK.OB), a bank holding company, revealed on Friday that its wholly owned subsidiary Highlands State Bank (the bank) signed a definitive agreement to acquire mortgage banking company Secured Lending Solutions Inc (SLS) of Glen Rock, New Jersey.

Highlands State Bank to Acquire Secure Lending Solutions Mortgage Company
Business Wire - Fri Oct 25, 2:28PM CDT
Highlands Bancorp, Inc. (OTCBB: HSBK.OB) announced that its wholly owned subsidiary, Highlands State Bank, has entered into a definitive agreement to acquire the mortgage banking company Secured Lending Solutions, Inc. ("SLS") of Glen Rock, NJ. SLS will be operated as a wholly owned subsidiary of the bank upon completion of standard regulatory approvals and normal acquisition conditions.

Highlands Bancorp, Inc. Reports Improved Results for the Three and Nine Months Ended September 30, 2013
Business Wire - Thu Oct 17, 11:51AM CDT
Highlands Bancorp, Inc. (OTCQB: HSBK) parent company of Highlands State Bank, reported third quarter 2013 net income of $326,000 compared to net income of $167,000 for the same period in 2012. For the nine months ended September 30, 2013 net income was $730,000 compared to a net income of $536,000 for the same period in 2012. Third quarter 2013 net income available to common stockholders was $603,000 or $.34 per diluted common share compared to net income of $154,000 or $.09 per diluted common share for the same period in 2012. The comparable nine month results reflect net income available to common stockholders for 2013 of $1,656,000 or $.93 per diluted common share compared to net income of $490,000 or $.27 per diluted common share. The third quarter and year-to-date 2013 results were positively impacted by partial reversals of the Company's valuation allowance on deferred tax assets of $425,000 and $1,274,000 respectively, which were partially offset by respective period income tax expenses of $131,000, and $297,000, respectively. These resulted in net tax benefits of $294,000 or $.16 per share for the third quarter 2013, and $977,000 or $.55 per share for the nine months ended September 30, 2013.

Highlands Bancorp, Inc. Reports Results for the Three and Six Months Ended June 30, 2013
Business Wire - Thu Jul 18, 4:31PM CDT
Highlands Bancorp, Inc. (OTCQB: HSBK) parent company of Highlands State Bank, reported second quarter 2013 net income of $225,000 compared to net income of $204,000 for the same period in 2012. For the six months ended June 30, 2013 net income was $404,000 compared to a net income of $369,000 for the same period in 2012. Second quarter 2013 net income available to common stockholders was $538,000 or $.30 per diluted common share compared to net income of $177,000 or $.10 per diluted common share for the same period in 2012. The comparable six month results reflect net income available to common stockholders for 2013 of $1,053,000 or $.59 per diluted common share compared to net income of $336,000 or $.19 per diluted common share. The second quarter and year-to-date 2013 results were positively impacted by partial reversals of the Company's valuation allowance on deferred tax assets of $425,000 and $849,000 respectively, which were partially offset by respective period income tax expenses of $95,000, and $167,000, respectively. These resulted in net tax benefits of $330,000 or $.18 per share for the second quarter 2013, and $682,000 or $.38 per share for the first six months of 2013.

Highlands Bancorp, Inc. Reports Increased Net Income and Earnings Per Share for the First Quarter Ended March 31, 2013
Business Wire - Wed Apr 17, 12:20PM CDT
Highlands Bancorp, Inc. (OTCBB: HSBK.OB) parent company of Highlands State Bank, reported first quarter net income of $532,000 compared to net income of $165,000 for the same period in 2012. First quarter net income available to common stockholders was $515,000 or $.29 per diluted share, compared to $159,000 or $.09 per diluted share for the same period in 2012. The first quarter 2013 results were positively impacted by a partial reversal of $425,000 of the Company's valuation allowance on deferred tax assets which was partially offset by current period income tax expenses of $72,000, resulting in a tax benefit of $353,000 or $.20 per share.

Highlands Bancorp reports higher net income for Q4 2012 over prior year
M2 - Mon Feb 04, 3:59AM CST
Highlands Bancorp Inc (OTC BB:HSBK.OB), the parent company of Highlands State Bank, on Friday reported a net income available to common stockholders of USD995,000 or USD0.56 per diluted share for the fourth quarter of 2012, increased from the net income available to common stockholders of USD770,000 or USD0.43 per diluted share for the same period in 2011.

Highlands Bancorp, Inc. Reports Enhanced Results for the Quarter and Year Ended December 31, 2012
Business Wire - Fri Feb 01, 4:11PM CST
Highlands Bancorp, Inc. (OTC BB: HSBK.OB) parent company of Highlands State Bank, reported fourth quarter net income of $1,012,000 in 2012 compared to net income of $798,000 for the same period of 2011. Fourth quarter net income available to common stockholders was $995,000 or $.56 per diluted share in 2012 compared to $770,000 or $.43 per diluted share for the same period in 2011. Net income for the full year 2012 was $1,548,000 compared to $1,534,000 for the full year 2011. Net income available to common stockholders for the full year 2012 was $1,485,000 or $.83 per diluted share compared to $1,192,000 or $.67 per diluted share for the year of 2011. The quarterly and annual results for both 2012 and 2011 were positively impacted by partial reversals of the Company's valuation allowance on deferred tax assets which resulted in tax benefits of $640,000 or $.36 per share for 2012, and $480,000 or $.27 per share for 201

Highlands State Bknj (HSBK) Stock Research Links

HSBK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading